StratifAI

Dresden, Germany

Precision oncology company developing the next generation of biomarkers to advance cancer diagnostics with multimodal AI Platform Polaris‚Ñ¢.

$14.7M raised

Sep 2025

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has StratifAI raised?

StratifAI has raised $14.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.

Who are StratifAI's investors?

StratifAI's investors include Alven, Picus Capital, Debiopharm Group, MultiplexDX, Arve Capital.

Where is StratifAI headquartered?

StratifAI is headquartered in Dresden, Germany.

What does StratifAI do?

Precision oncology company developing the next generation of biomarkers to advance cancer diagnostics with multimodal AI Platform Polaris‚Ñ¢.

What stage is StratifAI at?

StratifAI is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 30, 2025.

MLA

"StratifAI — Funding & Investors." VCBacked, September 30, 2025, https://www.vcbacked.co/company/stratifai. Accessed July 18, 2026.

APA

VCBacked. (2025). StratifAI — Funding & Investors. Retrieved July 18, 2026, from https://www.vcbacked.co/company/stratifai

Wikipedia (cite web)

{{cite web |title=StratifAI — Funding & Investors |url=https://www.vcbacked.co/company/stratifai |website=VCBacked |access-date=July 18, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 30, 2025.